Skip to content

Paul L. Bernstein, MD

NPI 1255379392ActiveIndividual· Internal Medicine, Nephrology· Rochester, NY

Internal Medicine, Nephrology (MD) in Rochester, New York, licensed in CT and NY, with an NPI issued in June 2006. Part D covered 55 prescriptions written in 2024, 89% of them generic. Apellis Pharmaceuticals, Inc. reported $58.36 in payments in 2025, mostly food and beverage.

Overview

NPI1255379392
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 2, 2006
Last updated in NPPESJun 24, 2021
Certified by providerJun 24, 2021

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nephrology (CT)

Part D prescriptions in 2024

Prescriptions (claims)55 · 128 30-day fills
Patients19
Total drug cost$1,067
Generic share89% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$58.36 · 1 payment from 1 company
  • 2024$146.21 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Apellis Pharmaceuticals, Inc.$58.361

What the 2025 payments were for

  • Food and Beverage$58.36 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Nephrology providers in Rochester

All Internal Medicine, Nephrology providers in New York →